These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1124 related items for PubMed ID: 8938169
1. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J. Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169 [Abstract] [Full Text] [Related]
2. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group. Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837 [Abstract] [Full Text] [Related]
3. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. Hartley JL, Brown RM, Tybulewicz A, Hayes P, Wilson DC, Gillett P, McKiernan P. J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988 [Abstract] [Full Text] [Related]
4. [Diagnostic value of five serum markers for liver fibrosis]. Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J. Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388 [Abstract] [Full Text] [Related]
5. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients]. Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW. Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747 [Abstract] [Full Text] [Related]
6. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K. Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429 [Abstract] [Full Text] [Related]
7. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease. Testa E, Malfatti F, Milazzo S, Cordiviola C, Cotellessa T, Marabotto E, Giannini E, Ceppa P, Mamone M, Risso D, Testa R. Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647 [Abstract] [Full Text] [Related]
8. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS. Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171 [Abstract] [Full Text] [Related]
9. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132 [Abstract] [Full Text] [Related]
10. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases]. Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW. Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637 [Abstract] [Full Text] [Related]
12. Serum hyaluronic acid as a marker of hepatic fibrosis. Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T. J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578 [Abstract] [Full Text] [Related]
13. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease]. Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264 [Abstract] [Full Text] [Related]
14. [Study on the influence factors of the serum fibrosis markers]. Cai WM, Tao J, Weng HL, Liu RH. Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736 [Abstract] [Full Text] [Related]
15. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML. Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410 [Abstract] [Full Text] [Related]
16. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. Chen YP, Feng XR, Dai L, Ding HB, Zhang L. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522 [Abstract] [Full Text] [Related]
17. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S, Yukawa T, Uetake S, Yamauchi M. Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [Abstract] [Full Text] [Related]
18. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis. Xie SB, Yao JL, Zheng SS, Yao CL, Zheng RQ. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739 [Abstract] [Full Text] [Related]
19. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R. Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267 [Abstract] [Full Text] [Related]
20. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, Guzman-Granier E, Chevallier P, Tran C, Longo F, Schneider S, Piche T, Hebuterne X, Benzaken S, Rampal P. Gastroenterol Clin Biol; 2000 Jun; 24(6-7):626-30. PubMed ID: 10962384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]